Loading...

Abcam plc

ABCM•NASDAQ
Healthcare
Biotechnology
$23.99
$0.010(0.04%)

Abcam plc (ABCM) Stock Overview

Explore Abcam plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.5/100

Key Financials

Market Cap5.5B
P/E Ratio-480.45
EPS (TTM)$0.01
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$44.99

ABCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abcam plc (ABCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $44.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -480.45 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;